• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳头状甲状腺癌的分子特征:一种潜在的三lncRNA预后标志物

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.

作者信息

You Xin, Yang Sheng, Sui Jing, Wu Wenjuan, Liu Tong, Xu Siyi, Cheng Yanping, Kong Xiaoling, Liang Geyu, Yao Yongzhong

机构信息

Department of General Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People's Republic of China,

Department of General Surgery, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China,

出版信息

Cancer Manag Res. 2018 Oct 8;10:4297-4310. doi: 10.2147/CMAR.S174874. eCollection 2018.

DOI:10.2147/CMAR.S174874
PMID:30349364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6183593/
Abstract

PURPOSE

Papillary thyroid carcinoma (PTC), the most frequent type of malignant thyroid tumor, lacks novel and reliable biomarkers of patients' prognosis. In the current study, we mined The Cancer Genome Atlas (TCGA) to develop lncRNA signature of PTC.

PATIENTS AND METHODS

The intersection of PTC lncRNAs was obtained from the TCGA database using integrative computational method. By the univariate and multivariate Cox analysis, key lncRNAs were identified to construct the prognostic model. Then, all patients were divided into the high-risk group and low-risk group to perform the Kaplan-Meier (K-M) survival curves and time-dependent receiver operating characteristic (ROC) curve, estimating the prognostic power of the prognostic model. Functional enrichment analysis was also performed. Finally, we verified the results of the TCGA analysis by the Gene Expression Omnibus (GEO) databases and quantitative real-time PCR (qRT-PCR).

RESULTS

After the comprehensive analysis, a three-lncRNA signature (PRSS3P2, KRTAP5-AS1 and PWAR5) was obtained. Interestingly, patients with low-risk scores tended to gain obviously longer survival time, and the area under the time-dependent ROC curve was 0.739. Furthermore, gene ontology (GO) and pathway analysis revealed the tumorigenic and prognostic function of the three lncRNAs. We also found three potential transcription factors to help understand the mechanisms of the PTC-specific lncRNAs. Finally, the GEO databases and qRT-PCR validation were consistent with our TCGA bioinformatics results.

CONCLUSION

We built a three-lncRNA signature by mining the TCGA database, which could effectively predict the prognosis of PTC.

摘要

目的

甲状腺乳头状癌(PTC)是最常见的甲状腺恶性肿瘤类型,缺乏用于评估患者预后的新型可靠生物标志物。在本研究中,我们挖掘了癌症基因组图谱(TCGA)以开发PTC的lncRNA特征。

患者与方法

采用综合计算方法从TCGA数据库中获取PTC的lncRNAs交集。通过单因素和多因素Cox分析,鉴定关键lncRNAs以构建预后模型。然后,将所有患者分为高风险组和低风险组,绘制Kaplan-Meier(K-M)生存曲线和时间依赖性受试者工作特征(ROC)曲线,评估预后模型的预后预测能力。还进行了功能富集分析。最后,我们通过基因表达综合数据库(GEO)和定量实时PCR(qRT-PCR)验证了TCGA分析的结果。

结果

经过综合分析,获得了一个由三个lncRNA组成的特征(PRSS3P2、KRTAP5-AS1和PWAR5)。有趣的是,低风险评分的患者往往具有明显更长的生存时间,时间依赖性ROC曲线下面积为0.739。此外,基因本体(GO)和通路分析揭示了这三个lncRNAs的致瘤和预后功能。我们还发现了三个潜在的转录因子,有助于理解PTC特异性lncRNAs的机制。最后,GEO数据库和qRT-PCR验证结果与我们的TCGA生物信息学结果一致。

结论

我们通过挖掘TCGA数据库构建了一个由三个lncRNA组成的特征,可有效预测PTC的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/a095b07503b9/cmar-10-4297Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/f487f782f22f/cmar-10-4297Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/be4de7d1c99d/cmar-10-4297Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/d92efd2fd7b2/cmar-10-4297Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/3e8f7834b6f7/cmar-10-4297Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/a7b334206228/cmar-10-4297Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/da643505f4f5/cmar-10-4297Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/a095b07503b9/cmar-10-4297Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/f487f782f22f/cmar-10-4297Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/be4de7d1c99d/cmar-10-4297Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/d92efd2fd7b2/cmar-10-4297Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/3e8f7834b6f7/cmar-10-4297Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/a7b334206228/cmar-10-4297Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/da643505f4f5/cmar-10-4297Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eef5/6183593/a095b07503b9/cmar-10-4297Fig7.jpg

相似文献

1
Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.乳头状甲状腺癌的分子特征:一种潜在的三lncRNA预后标志物
Cancer Manag Res. 2018 Oct 8;10:4297-4310. doi: 10.2147/CMAR.S174874. eCollection 2018.
2
Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.肺腺癌的分子特征:一个潜在的四长非编码 RNA 预后特征。
J Cell Biochem. 2019 Jan;120(1):705-714. doi: 10.1002/jcb.27428. Epub 2018 Aug 20.
3
A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.潜在的九长链非编码 RNA 标志物鉴定和列线图诊断模型在甲状腺乳头状癌中的建立。
Pathol Oncol Res. 2022 Feb 23;28:1610012. doi: 10.3389/pore.2022.1610012. eCollection 2022.
4
Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.鉴定五基因特征并建立预测甲状腺乳头状癌无进展生存期的预后列线图。
Front Endocrinol (Lausanne). 2019 Nov 15;10:790. doi: 10.3389/fendo.2019.00790. eCollection 2019.
5
Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer.用于甲状腺乳头状癌有效诊断和预后的枢纽lncRNAs以及lncRNA-miRNA-mRNA网络的鉴定
Front Pharmacol. 2021 Oct 13;12:748867. doi: 10.3389/fphar.2021.748867. eCollection 2021.
6
Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.新型长非编码 RNA 标志物对乙型肝炎病毒相关肝细胞癌患者肝切除术后的预后影响及其与临床分期系统的比较。
J Dig Dis. 2020 Nov;21(11):650-663. doi: 10.1111/1751-2980.12941. Epub 2020 Oct 27.
7
A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.细胞周期相关长链非编码 RNA 标志物预测甲状腺乳头状癌无进展间隔。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1110987. doi: 10.3389/fendo.2023.1110987. eCollection 2023.
8
Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.鉴定和验证六个自噬相关长非编码 RNA 作为结直肠癌的预后标志物。
Int J Med Sci. 2021 Jan 1;18(1):88-98. doi: 10.7150/ijms.49449. eCollection 2021.
9
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.基于免疫相关长非编码 RNA 的上皮性卵巢癌预后模型。
J Ovarian Res. 2022 Jan 15;15(1):8. doi: 10.1186/s13048-021-00930-w.
10
Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.长非编码 RNA 谱研究鉴定出结直肠癌的一个代谢相关特征。
Mol Med. 2021 Aug 3;27(1):83. doi: 10.1186/s10020-021-00343-x.

引用本文的文献

1
Mechanistic role of the KRTAP5-AS1/miR-199b-5p/CYP19A1 axis in polycystic ovary syndrome pathogenesis.KRTAP5-AS1/miR-199b-5p/CYP19A1轴在多囊卵巢综合征发病机制中的作用机制
J Ovarian Res. 2025 Aug 8;18(1):176. doi: 10.1186/s13048-025-01746-8.
2
Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data.通过整合全基因组关联研究(GWAS)和表达数量性状基因座(eQTL)汇总数据来确定静脉曲张的潜在药物靶点。
Front Genet. 2024 May 15;15:1385293. doi: 10.3389/fgene.2024.1385293. eCollection 2024.
3
Identification of the potential regulatory interactions in rheumatoid arthritis through a comprehensive analysis of lncRNA-related ceRNA networks.

本文引用的文献

1
Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer.大花红景天苷B调节关键代谢途径以增强活性氧生成并诱导结直肠癌细胞的细胞毒性和凋亡。
Cell Physiol Biochem. 2018;46(4):1317-1330. doi: 10.1159/000489147. Epub 2018 Apr 18.
2
Integrated analysis of long non‑coding RNA competing interactions revealed potential biomarkers in cervical cancer: Based on a public database.基于公共数据库的长链非编码 RNA 竞争相互作用综合分析揭示宫颈癌的潜在标志物
Mol Med Rep. 2018 Jun;17(6):7845-7858. doi: 10.3892/mmr.2018.8846. Epub 2018 Apr 5.
3
Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
通过全面分析 lncRNA 相关 ceRNA 网络鉴定类风湿关节炎中的潜在调控相互作用。
BMC Musculoskelet Disord. 2023 Oct 9;24(1):799. doi: 10.1186/s12891-023-06936-3.
4
Predictive Role of a Novel Ferroptosis-Related lncRNA Pairs Model in the Prognosis of Papillary Thyroid Carcinoma.一种新型铁死亡相关长链非编码RNA对模型在甲状腺乳头状癌预后中的预测作用
Biochem Genet. 2024 Apr;62(2):775-797. doi: 10.1007/s10528-023-10447-0. Epub 2023 Jul 12.
5
A Novel Constitutional t(3;8)(p26;q21) and and Variants in a Child with Myelodysplastic Neoplasm: Clinical Implications.一名骨髓增生异常肿瘤患儿中的新型染色体结构变异t(3;8)(p26;q21)及其他变异:临床意义
J Clin Med. 2023 Apr 28;12(9):3171. doi: 10.3390/jcm12093171.
6
Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer.术前血清促甲状腺激素和甲状腺激素浓度联合对甲状腺乳头状癌的预后价值。
J Clin Lab Anal. 2022 Jul;36(7):e24503. doi: 10.1002/jcla.24503. Epub 2022 Jun 6.
7
hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B.hsa-miR-206b 通过靶向 LMX1B 参与甲状腺乳头状癌的发生。
Biomed Res Int. 2022 Mar 15;2022:7488708. doi: 10.1155/2022/7488708. eCollection 2022.
8
The landscape of tumors-infiltrate immune cells in papillary thyroid carcinoma and its prognostic value.乳头状甲状腺癌中肿瘤浸润免疫细胞的格局及其预后价值。
PeerJ. 2021 May 21;9:e11494. doi: 10.7717/peerj.11494. eCollection 2021.
9
Genome-Wide Analysis of the FOXA1 Transcriptional Network Identifies Novel Protein-Coding and Long Noncoding RNA Targets in Colorectal Cancer Cells.全基因组分析 FOXA1 转录网络鉴定结直肠癌细胞中新的蛋白编码和长非编码 RNA 靶标。
Mol Cell Biol. 2020 Oct 13;40(21). doi: 10.1128/MCB.00224-20.
10
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?原发灶转移与非转移甲状腺乳头状癌基因表达谱的差异——是否存在?
Int J Mol Sci. 2020 Jun 29;21(13):4629. doi: 10.3390/ijms21134629.
长非编码 RNA RP5-821D11.7、APCDD1L-AS1 和 RP11-277P12.9 与肺鳞状细胞癌的预后相关。
Mol Med Rep. 2018 May;17(5):7238-7248. doi: 10.3892/mmr.2018.8770. Epub 2018 Mar 16.
4
Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer.甲状腺癌血清多肽标志物的检测与鉴定
Med Sci Monit. 2018 Mar 17;24:1581-1587. doi: 10.12659/msm.907768.
5
Development and validation of an individualized diagnostic signature in thyroid cancer.甲状腺癌个体化诊断标志物的建立与验证。
Cancer Med. 2018 Apr;7(4):1135-1140. doi: 10.1002/cam4.1397. Epub 2018 Mar 9.
6
Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.尿液中的无细胞长链非编码 RNA 表达特征可作为膀胱癌诊断和复发预测的新型无创生物标志物。
J Cell Mol Med. 2018 May;22(5):2838-2845. doi: 10.1111/jcmm.13578. Epub 2018 Mar 8.
7
The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.长链非编码 RNA FOXD2-AS1 通过与 Akt 和 E2F1 的正反馈环路促进膀胱癌的进展和复发。
Cell Death Dis. 2018 Feb 14;9(2):233. doi: 10.1038/s41419-018-0275-9.
8
Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults.二甲双胍调节老年人骨骼肌和皮下脂肪组织的代谢和非代谢途径。
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12723. Epub 2018 Jan 31.
9
Treatment of refractory thyroid cancer.治疗难治性甲状腺癌。
Endocr Relat Cancer. 2018 Apr;25(4):R209-R223. doi: 10.1530/ERC-17-0542. Epub 2018 Jan 25.
10
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.构建并探究甲状腺乳头状癌中 lncRNA 相关 ceRNA 调控网络。
Oncol Rep. 2018 Mar;39(3):1197-1206. doi: 10.3892/or.2018.6207. Epub 2018 Jan 10.